A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2
Authors
Keywords
-
Journal
ACTA ONCOLOGICA
Volume 55, Issue 3, Pages 341-348
Publisher
Informa UK Limited
Online
2015-10-09
DOI
10.3109/0284186x.2015.1091499
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Health Economic Changes as a Result of Implementation of Targeted Therapy for Metastatic Renal Cell Carcinoma: National Results from DARENCA Study 2
- (2015) Anne V. Soerensen et al. EUROPEAN UROLOGY
- Hypertension During Vascular Endothelial Growth Factor Inhibition: Focus on Nitric Oxide, Endothelin-1, and Oxidative Stress
- (2013) Stephanie Lankhorst et al. ANTIOXIDANTS & REDOX SIGNALING
- Improved overall survival after implementation of targeted therapy for patients with metastatic renal cell carcinoma: Results from the Danish Renal Cancer Group (DARENCA) study-2
- (2013) Anne V. Soerensen et al. EUROPEAN JOURNAL OF CANCER
- The Impact of Low Serum Sodium on Treatment Outcome of Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Cancer Database Consortium
- (2013) Fabio A.B. Schutz et al. EUROPEAN UROLOGY
- Mild hyponatremia is associated with an increased risk of death in an ambulatory setting
- (2013) Fabrice Gankam-Kengne et al. KIDNEY INTERNATIONAL
- External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study
- (2013) Daniel YC Heng et al. LANCET ONCOLOGY
- Impact of hyponatremia on survival of patients with metastatic renal cell carcinoma treated with molecular targeted therapy
- (2012) Atsunari Kawashima et al. INTERNATIONAL JOURNAL OF UROLOGY
- Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials
- (2012) Hai T Tran et al. LANCET ONCOLOGY
- Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma
- (2011) Petri Bono et al. ACTA ONCOLOGICA
- The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy
- (2011) Robyn Macfarlane et al. CANCER
- Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
- (2011) Judith Manola et al. CLINICAL CANCER RESEARCH
- IL-6 plays an essential role in neutrophilia under inflammation
- (2011) Misato Hashizume et al. CYTOKINE
- Hypertension as a Biomarker of Efficacy in Patients With Metastatic Renal Cell Carcinoma Treated With Sunitinib
- (2011) B. I. Rini et al. JNCI-Journal of the National Cancer Institute
- Hyponatremia as a prognostic and predictive factor in metastatic renal cell carcinoma
- (2010) A N Jeppesen et al. BRITISH JOURNAL OF CANCER
- Hypothyroidism in patients with renal cell carcinoma
- (2010) Manuela Schmidinger et al. CANCER
- Moving towards dose individualization of tyrosine kinase inhibitors
- (2010) Heinz-Josef Klümpen et al. CANCER TREATMENT REVIEWS
- Hypothyroidism correlates with a better prognosis in metastatic renal cancer patients treated with sorafenib or sunitinib
- (2010) L. M. Riesenbeck et al. WORLD JOURNAL OF UROLOGY
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search